ArticleJournal for immunotherapy of cancer2025

Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer.

Yujing Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.